Abstract
The minimal inhibitory concentration of 5-fluorocytosine in 18 pathogenic fungal isolates was not altered by either allopurinol (100 μM) or oxypurinol (100 μM). Since allopurinol at this level clinically has been demonstrated to interfere with 5-fluorouracil anabolism, thereby reducing toxicity owing to 5-fluorouracil, allopurinol may be useful in counteracting the 5-fluorouracil-induced myelotoxicity observed in patients being treated with 5-fluorocytosine without interfering with the antifungal activity of 5-fluorocytosine.
Original language | English (US) |
---|---|
Pages (from-to) | 448-449 |
Number of pages | 2 |
Journal | Unknown Journal |
Volume | 24 |
Issue number | 3 |
DOIs | |
State | Published - 1983 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases